Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKM | P14618 | 2/20 | 0.34 |
| ▸ | CYP11B1 | P15538 | 7/20 | 0.33 |
| ▸ | CYP11B2 | P19099 | 7/20 | 0.33 |
| ▸ | GRM5 | P41594 | 1/20 | 0.32 |
| ▸ | MAOA | P21397 | 1/20 | 0.32 |
| ▸ | MAOB | P27338 | 1/20 | 0.32 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.31 |
| ▸ | BRD4 | O60885 | 1/20 | 0.31 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.31 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.30 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.30 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.30 |
| ▸ | PIK3CA | P42336 | 2/20 | 0.30 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.30 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.30 |
| ▸ | PRKDC | P78527 | 1/20 | 0.30 |
| ▸ | PTGES | O14684 | 1/20 | 0.30 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.30 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.30 |
| ▸ | FECH | P22830 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31397115 | 0.82 | GRM5 (0.33) | PKMCYP11B1CYP11B2GRM5MAOA | |
| SCHEMBL31397293 | 0.81 | GRM5 (0.32) | PKMCYP11B1CYP11B2GRM5PIK3CA | |
| SCHEMBL23540770 | 0.80 | TLR9 (0.34) | GRM5 | |
| SCHEMBL31397182 | 0.80 | BRD4 (0.32) | GRM5BRD4CREBBP | |
| SCHEMBL31397542 | 0.80 | PKM (0.40) | PKMGRM5MAOAMAOBMAPK14 | |
| SCHEMBL31397188 | 0.79 | MCHR1 (0.36) | PKMGRM5PIK3CAKCNH2MCHR1 | |
| SCHEMBL30274180 | 0.78 | PKM (0.41) | PKMGRM5MAOAMAOBPIK3CA | |
| SCHEMBL31397381 | 0.77 | MCHR1 (0.41) | GRM5PIK3CAKCNH2MCHR1PIK3CD | |
| SCHEMBL31520767 | 0.77 | CNR1 (0.43) | PKMGRM5MAOAMAOB | |
| SCHEMBL23540513 | 0.77 | PKM (0.40) | PKMGRM5MAOAMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240424111-A1 | Degrader Compounds and Uses Thereof | CALICO LIFE SCIENCES LLC (US) | 2024-12-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240424111-A1 | Degrader Compounds and Uses Thereof | PTPN1, PTPN2, PTPN5 | PKM 1599/4885CYP11B1 3067/4885CYP11B2 3021/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.